Bone Fractures

3

Review clinical trials related to Bone Fractures. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Naringenin Supplementation in Bone Fracture Patients

Fractures of the lower extremities represent a significant proportion of injuries sustained by polytrauma patients, with a notable association with prolonged hospitalization, chronic disability, and impaired physical functioning. The occurrence of surgical site infections (SSI) represents a significant threat to the efficacy of osteosynthesis procedures. As with other traumas and surgical procedures, the secretion of inflammatory mediators is markedly elevated in this cohort of patients following surgery. Naringenin is one of the most prevalent flavonoids, occurring naturally in grapefruit and other citrus fruits. In vitro studies have demonstrated that naringenin may stimulate the release of osteogenic cytokines and suppress the production of pro-inflammatory factors, which can result in a reduction in bone resorption. Based on these findings, naringenin may prove an effective agent for accelerating the rate of fusion and controlling inflammation. Furthermore, it may enhance quality of life and augment functional activity.

Participants needed: 70
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Shahid Beheshti University of Medical SciencesUpdated: Feb 24, 2026Locations: 1
Eligibility criteria

Candidate for orthopedic surgery for bone fractures of the lower limbs, [+5]

Allergy or intolerant reaction to narangenin capsules [+2]

Status: Recruiting

Opioid Management for Discharged Emergency Department Patients

The goal of this study is to analyze the use of the Addinex system for opioid dispensing after ambulatory care to determine whether it will reduce opioid consumption, increase pill disposal, show variables that may predict opioid consumption, and determine whether this intervention is acceptable to patients.

Participants needed: 100
Trial details
Age: 6+Biological sex: AllType: InterventionalSponsor: Addinex Technologies, Inc.Updated: Dec 26, 2025Locations: 1
Eligibility criteria

Ages six years and older [+9]

Recent opioid use (last 30 days or 2 or more prescriptions in the past 3 months [+3]

Status: Recruiting

Study on Safety and Performance of AdvanCore Bone Void Filler

The objective of this study is to evaluate the safety and performance of AdvanCore implantable bone graft through a 12-month follow-up period in a prospective, parallel-group design, non-controlled, open label, multi-center and real-world setting study. This study is intended to satisfy post-market clinical follow-up requirements of CE Mark in Europe.

Participants needed: 190
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Artur Salgado SAUpdated: May 31, 2025Locations: 4
Eligibility criteria

Adult subjects ≥ 18 years old, male or female. [+4]

Subjects with any AdvanCore contraindication for implantation or use. [+4]